Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics
PROTEOMICS – Clinical Applications · 2025
DOI: 10.1002/prca.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2025. Verfasst von Pingping Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aier Eye Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Choroidal Effusions, Glucocorticoids, Retinal Detachment, Anti-Inflammatory Agents. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Purpose
Glucocorticoids are widely used for their anti‐inflammatory properties, but their specific molecular mechanisms in treating rhegmatogenous retinal detachment with choroidal detachment (RRDCD) remain unclear. This study aims to identify key regulatory factors in the vitreous humor of RRDCD patients and analyze protein changes after hormonal intervention.
Methods
Vitreous fluid samples were collected during surgery from patients with rhegmatogenous retinal detachment (RRD, n = 40), non‐glucocorticoid treated RRDCD (nT‐RRDCD, n = 35), and glucocorticoid‐treated RRDCD (T‐RRDCD, n = 32). Primary outcomes were retinal reattachment status and best‐corrected visual acuity (BCVA) at 6 months postoperatively. Proteomic analysis was performed using data‐independent acquisition (DIA), with differentially expressed proteins validated by parallel reaction monitoring (PRM) and ELISA.
Results
Between RRD and nT‐RRDCD, 203 differentially expressed proteins were identified, while 295 proteins were differentially expressed between nT‐RRDCD and T‐RRDCD. These proteins were involved in complement activation, immune response, blood coagulation, and MAPK signaling. Apolipoprotein D (APOD) and vitronectin (VTN) positively correlated with postoperative BCVA. APOD, serum amyloid A‐4 (SAA4), and ubiquitin‐conjugating enzyme E2 variant emerged as potential diagnostic biomarkers for RRDCD.
Conclusions
RRDCD development involves multiple factors. Glucocorticoids mitigate retinal damage by suppressing inflammation, regulating oxidative stress, and promoting cell repair. APOD and VTN correlate with BCVA, while APOD, SAA4, and ubiquitin‐conjugating enzyme E2 show promise as diagnostic biomarkers for RRDCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Aier Eye Hospital of Wuhan University, Wuhan, China.
- Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Pingping Li, Lu Li
Zitieren
APA
Li, P., Han, M., Zhang, R., Chen, F., Li, Y., Yuan, J., Ma, N., Li, L., & Wu, J. (2025). Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.70008
Vancouver
Li P, Han M, Zhang R, Chen F, Li Y, Yuan J, et al. Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. 2025. doi:10.1002/prca.70008
BibTeX
@article{Li2025,
author = {Li, Pingping and Han, Mengyao and Zhang, Rui and Chen, Fangyu and Li, Yanzi and Yuan, Jing and Ma, Ning and Li, Lu and Wu, Jianhua},
title = {Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics},
journal = {PROTEOMICS – Clinical Applications},
year = {2025},
doi = {10.1002/prca.70008}
}
EUVIMED